Skip to main content

Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract

In this study, double-stranded Candida albicans DNA was administered in systemic C. albicans infection in at dose of 20 g per mouse at 4, 5 and 6 weeks of age. The level of IL-12 in serum was elevated as a result of yeast DNA treatment and correlated with lower mortality and decreased kidney and liver injury. Macrophage activation was demonstrated by an increase of nitric oxide (NO) and IL-12 production. These effects were Janus activation kinases (JAK)/signal transducer and activator of transcription (STAT) dependent as they were inhibited by selective JAK inhibitor tyrphostin AG-490. DNA influenced adaptive immune response through elevation of anti-Candida IgG antibody production in systemic C. albicans infection. Thus, C. albicans DNA augmented innate and adaptive immune responses against the pathogen.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: C. albicans DNA; Candida albicans infection; IL-12; tyrphostin AG-490

Document Type: Research Article

Affiliations: 1: Department of Immunology, Institute of Microbiology, Sofia, Bulgaria; and 2: Department of Genetics, Institute of Microbiology, Sofia, Bulgaria

Publication date: 2008-07-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more